John K Bell - Net Worth and Insider Trading
John K Bell Net Worth
The estimated net worth of John K Bell is at least $115 dollars as of 2024-05-15. John K Bell is the Director of Kintara Therapeutics Inc and owns about 894 shares of Kintara Therapeutics Inc (KTRA) stock worth over $115. Details can be seen in John K Bell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John K Bell has not made any transactions after 2019-09-13 and currently still holds the listed stock(s).
Transaction Summary of John K Bell
John K Bell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John K Bell owns 2 companies in total, including Kintara Therapeutics Inc (KTRA) , and Avenir Wellness Solutions Inc (AVRW) .
Click here to see the complete history of John K Bell’s form 4 insider trades.
Insider Ownership Summary of John K Bell
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KTRA | Kintara Therapeutics Inc | 2019-09-13 | director |
| AVRW | Avenir Wellness Solutions Inc | 2019-11-18 | director |
John K Bell Latest Holdings Summary
John K Bell currently owns a total of 1 stock. John K Bell owns 894 shares of Kintara Therapeutics Inc (KTRA) as of September 13, 2019, with a value of $115.
Latest Holdings of John K Bell
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KTRA | Kintara Therapeutics Inc | 2019-09-13 | 894 | 0.13 | 115 |
Holding Weightings of John K Bell
John K Bell Form 4 Trading Tracker
According to the SEC Form 4 filings, John K Bell has made a total of 2 transactions in Kintara Therapeutics Inc (KTRA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Kintara Therapeutics Inc is the acquisition of 700 shares on September 13, 2019, which cost John K Bell around $23,800.
Insider Trading History of John K Bell
- 1
John K Bell Trading Performance
GuruFocus tracks the stock performance after each of John K Bell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John K Bell is -20.39%. GuruFocus also compares John K Bell's trading performance to market benchmark return within the same time period. The performance of stocks bought by John K Bell within 3 months outperforms 1 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John K Bell's insider trading performs compared to the benchmark.
Performance of John K Bell
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -16.45 | | | | | |
| Relative Return to S&P 500(%) | -16.82 | | | | | |
John K Bell Ownership Network
John K Bell Owned Company Details
What does Kintara Therapeutics Inc do?
Who are the key executives at Kintara Therapeutics Inc?
John K Bell is the director of Kintara Therapeutics Inc. Other key executives at Kintara Therapeutics Inc include director & President and CEO Robert Hoffman , Chief Financial Officer Anthony Scott Praill , and director & Head of Strategic Partnerships Saiid Zarrabian .
Kintara Therapeutics Inc (KTRA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Kintara Therapeutics Inc (KTRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kintara Therapeutics Inc (KTRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Kintara Therapeutics Inc (KTRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kintara Therapeutics Inc Insider Transactions
John K Bell Mailing Address
Above is the net worth, insider trading, and ownership report for John K Bell. You might contact John K Bell via mailing address: 38 Fallbrook Lane Rr 33, Cambridge A6 N3h 4r8.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
